Phase 3 Clinical Study for the Treatment of Cold Sore
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
To demonstrate the efficacy of a single dose of acyclovir Lauriad® 50mg muco-adhesive buccal
tablet versus a single dose of matching placebo on the primary vesicular lesion of cold sore.